Lian Cao

Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study

Xia Li, Haifeng Zhao, Jia Fan, 2022, Cancer medicine.